Patient-Derived Xenograft Models to Improve Targeted Therapy in Epithelial Ovarian Cancer Treatment

Despite increasing evidence that precision therapy targeted to the molecular drivers of a cancer has the potential to improve clinical outcomes, high-grade epithelial ovarian cancer (OC) patients are currently treated without consideration of molecular phenotype, and predictive biomarkers that could...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Clare L., Becker, Marc A., Haluska, Paul, Samimi, Goli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849703/
https://www.ncbi.nlm.nih.gov/pubmed/24363999
http://dx.doi.org/10.3389/fonc.2013.00295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849703/
https://www.ncbi.nlm.nih.gov/pubmed/24363999
http://dx.doi.org/10.3389/fonc.2013.00295

Ejemplares similares